Bonga, Datu Jedh M.

HRN: 29-33-69  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2026
07/27/2026
IV
2.25G
Q6HRS
AP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: